AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Biohit Oyj

Remuneration Information • Mar 22, 2023

3304_rpt_2023-03-22_5581867e-337c-42f6-b994-b026e330dc37.pdf

Remuneration Information

Open in Viewer

Opens in native device viewer

Publication of Biohit Oyj Renumeration Report 2022

Biohit Oyj Renumeration Report March 22, 2023 at 9:30 am local time (EET)

Biohit Oyj's Remuneration Report for the Governing Bodies is published today in PDF format. The Remuneration Report for the Governing Bodies is attached to this stock exchange release and also available at http://www.biohithealthcare.com/en/investors/.

Additional information:

CEO Jussi Hahtela, Biohit Oyj tel. +358 9 773 861 [email protected] www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is "Innovating for Health" – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com